The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals

Atherosclerosis

Volumn 181, Issue 2, 2005, Pages 275-284

  Verschuur, Maartje ^a,b   Jellema, Annemarie ^c,d   Bladbjerg, Else M ^e,f   Feskens, Edith J M ^d   Mensink, Ronald P ^c   Møller, Lars ^g   Vos, Hans L ^a   De Maat, Moniek P M ^b,h  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f ESBJERG HOSPITAL   (Denmark)

^g GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

BMI; Genetic variation; PAI 1; Promoter haplotypes

Indexed keywords

ADENINE; GUANINE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BODY MASS; CELL STRAIN; CELL STRAIN HEPG2; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; REPORTER GENE;

ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; GENES, REPORTER; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 22544485112     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.01.036     Document Type: Article

References (32)

1. J.H. Heaton, V.L. Nebes, L.G. O'Dell, S.M. Morris Jr., and T.D. Gelehrter Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes Mol Endocrinol 3 1989 185 192
2. T. Bourcier, and P. Libby HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells Arterioscler Thromb Vasc Biol 20 2000 556 562
3. V. van Harmelen, H. Wahrenberg, P. Eriksson, and P. Arner Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue Thromb Haemost 83 2000 304 308
4. J. Aznar, A. Estelles, and G. Tormo Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease Br Heart J 59 1988 535 541
5. A.R. Folsom Hemostatic risk factors for atherothrombotic disease: an epidemiologic view Thromb Haemost 86 2001 366 373
6. I. Juhan-Vague, and M.C. Alessi PAI-1, obesity, insulin resistance and risk of cardiovascular events Thromb Haemost 78 1997 656 660
7. M. de Lange, H. Snieder, R.A.S. Ariens, T.D. Spector, and P.J. Grant The genetics of haemostasis: a twin study Lancet 357 2001 101 105
8. M. Henry, N. Chomiki, and P.Y. Scarabin Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population Arterioscler Thromb Vasc Biol 17 1997 851 858
9. S. Dawson, A. Hamsten, B. Wiman, and A. Henney Humphries S: genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity Arterioscler Thromb 11 1991 183 190
10. P. Eriksson, B. Kallin, F.M. van't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci USA 92 1995 1851 1855
11. N. Ossei-Gerning, M.W. Mansfield, M.H. Stickland, I.J. Wilson, and P.J. Grant Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography Arterioscler Thromb Vasc Biol 17 1997 33 37
12. S.M. Boekholdt, N.R. Bijsterveld, and A.H. Moons Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review Circulation 104 2001 3063 3068
13. S.J. Dawson, B. Wiman, and A. Hamsten The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells J Biol Chem 268 1993 10739 10745
14. H.E. Grenett, R.L. Benza, and G.M. Fless Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells Arterioscler Thromb Vasc Biol 18 1998 1803 1809
15. M.W. Mansfield, M.H. Stickland, and P.J. Grant Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus Thromb Haemost 74 1995 842 847
16. P.E. Morange, M. Henry, and D. Tregouet The A-844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers Arterioscler Thromb Vasc Biol 20 2000 1387 1391
17. N. Grubic, M. Stegnar, P. Peternel, A. Kaider, and B.R. Binder A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis Thromb Res 84 1996 431 443
18. M.P. de Maat, E.M. Bladbjerg, and T. Drivsholm Inflammation, thrombosis and atherosclerosis: results of the Glostrup study J Thromb Haemost 1 2003 950 957
19. A. Jellema, R.P. Mensink, D. Kromhout, W.H. Saris, and E.J. Feskens Metabolic risk markers in an overweight and normal weight population with oversampling of carriers of the IRS-1972Arg-variant Atherosclerosis 171 2003 75 81
20. R.M. van Dam, J.M. Boer, E.J. Feskens, and J.C. Seidell Parental history of diabetes modifies the association between abdominal adiposity and hyperglycemia Diabetes Care 24 2001 1454 1459
21. H. Hollnagel The health structure of 40-year-old men and women in the Glostrup area, Denmark - an epidemiological survey. General design, sampling results and referrals for further medical care Dan Med Bull 27 1980 121 130
22. L.G.M. Huisman, P. Meijer, J. vanGriensven, and C. Kluft Evaluation of the specificity of antigen assays for plasminogen activator inhibitor 1: comparison of two new commercial kits Fibrinolysis 6 1992 87 88
23. J. Sambrook, E. Fritsch, and T. Maniatis Expression of cloned genes in cultured mammalian cells N. Ford C. Nolan M. Ferguson Molecular cloning: a laboratory manual 2003 Cold Spring Harbor Laboratory Press 33
24. S. Schneider, D. Roessli, and L. Excoffier Arlequin: a software for population genetics data analysis, Ver 2.000 2000 Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva
25. C.J. Doggen, R.M. Bertina, V.M. Cats, P.H. Reitsma, and F.R. Rosendaal The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction Thromb Haemost 82 1999 115 120
26. M. Henry, D.A. Tregoudt, and M.C. Alessi Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort Arterioscler Thromb Vasc Biol 18 1998 84 91
27. M.T. Sartori, R. Vettor, and G. De Pergola Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance Thromb Haemost 86 2001 1161 1169
28. K. Leander, B. Wiman, J. Hallqvist, M. Sten-Linder, and U. de Faire PAI-1 level and the PAI-14G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP) Thromb Haemost 89 2003 1064 1071
29. Y.Q. Chen, J. Sloan-Lancaster, and D.T. Berg Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells Thromb Haemost 86 2001 1563 1572
30. L.R. Lund, B. Georg, and L.S. Nielsen Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay Mol Cell Endocrinol 60 1988 43 53
31. J.G. van der Bom, M.L. Bots, F. Haverkate, C. Kluft, and D.E. Grobbee The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1 Blood 101 2003 1841 1844
32. M.W. Mansfield, M.H. Stickland, and P.J. Grant PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations Thromb Haemost 77 1997 357 361